Browsing: GNS

AIM-listed veterinary products firm Animalcare (ANCR) has agreed a takeover by CPP Paw 2, backed by Charterhouse Capital. The cash…

Animal genetics company Genus (GNS) has revealed 1H trading was ahead of expectations. It now expects pre-tax profit of £50…

GENUS (GNS) – Pharmaceuticals Price: £25.27 +6.4%P/E: 39.8xMarket Cap: £1.59bnYield: 1.38% Animal genetics firm Genus has released a short trading…